Author

Jacinda Tran

Observed name: J. Tran

Institution: University of Washington

Observed institutions: Gates Foundation, University of Washington, AbbVie (United States), Institute for Disease Modeling

ORCID: 0000-0002-8414-7303

Observed ORCID: 0000-0002-8414-7303

OpenAlex ID: A5034260460

Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data

2023 · Silvio Danese, Jacinda Tran, et al. · Inflammatory Bowel Diseases · 26

Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results

2023 · Julian Panés, Edward V Loftus, et al. · Inflammatory Bowel Diseases · 19

Patient preferences for long-acting HIV treatment: a preference heterogeneity assessment

2025 · Enrique M. Saldarriaga, Brett Hauber, et al. · BMC Infectious Diseases · 9

Comparative Efficacy and Safety of Upadacitinib vs. Vedolizumab, Ustekinumab, and Tofacitinib After Induction and Maintenance for Ulcerative Colitis: Three Matching-Adjusted Indirect Comparisons

2024 · Walter Reinisch, Gil Y. Melmed, et al. · Advances in Therapy · 8

Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya

2024 · Anne Kaggiah, Catherine N. Maina, et al. · BMC Infectious Diseases · 5

Cost-effectiveness of single-visit cervical cancer screening in KwaZulu-Natal, South Africa: a model-based analysis accounting for the HIV epidemic

2024 · Jacinda Tran, Christine Lee Hathaway, et al. · Frontiers in Oncology · 4

Bridging PrEP access gaps: Mapping geospatial accessibility across the United States and leveraging community pharmacies for expansion

2024 · Jacinda Tran, Anu Mishra, et al. · Journal of the American Pharmacists Association · 3

Adaptation and pilot testing of a discrete choice experiment and survey on patient preferences for long-acting antiretroviral therapies for HIV in Kenya

2025 · Catherine N. Maina, Anne W. Kaggiah, et al. · AIDS Care · 2

SC4 The Clinical and Economic Impacts of Pharmacist-Initiated Pre-Exposure Prophylaxis for Men Who Have Sex with Men in the United States: A Cost-Utility Analysis

2021 · J. Tran, M. Zimmermann · Value in Health · 1

Health economic impact and cost threshold for switching from bivalent to nonavalent HPV vaccination for preadolescent girls in KwaZulu Natal, South Africa: A mathematical modeling analysis accounting for the HIV epidemic

2026 · Christine L. Hathaway, Jacinda Tran, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes

Heterogeneity of patient preferences for long-acting HIV treatment among people with HIV in Kenya

2026 · Enrique M. Saldarriaga, Brett Hauber, et al. · BMC Infectious Diseases

Patient preferences for long-acting antiretroviral treatment among people with HIV in Kenya: a discrete choice experiment

2026 · Jacinda Tran, Enrique M. Saldarriaga, et al. · BMC Infectious Diseases

PCR101 Association of Chronic Conditions and Medication Burden with Patient Preferences for Long-Acting Antiretroviral Therapy in HIV Treatment

2025 · Zilin Cheng, Douglas Barthold, et al. · Value in Health

Relationship between Home Availability of Fruit and Vegetables and Food Choice in 8 to 10 year old New Zealand Children

2014 · Jacinda Tran · Otago University Research Archive (University of Otago)

Works count: 14

Citation count: 77

H-index: 5

I10-index: 2